Home/Filings/4/0000310158-25-000056
4//SEC Filing

Williams David Michael 4

Accession 0000310158-25-000056

CIK 0000310158other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:02 PM ET

Size

5.3 KB

Accession

0000310158-25-000056

Insider Transaction Report

Form 4
Period: 2025-11-03
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
  • Sale

    Common Stock

    2025-11-03$83.59/sh8,614$720,04024,578.031 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.5400 to $83.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001820958

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:02 PM ET
Size
5.3 KB